We assessed whether the impaired functionality of HCV-specific CD4+ and CD8+ T cells manifested by reduced T helper 1 cytokine production (IL2 and IFN-Ɣ) during chronic hepatitis C is restored upon HCV clearance with DAA treatments. The gene discussed is CD4; the disease is chronic hepatitis C virus infection.